These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7503483)

  • 41. Treatment of acute hepatitis C-how to explain the differences?
    Wedemeyer H; Cornberg M; Wiegand J; Jäckel E; Manns MP
    Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627
    [No Abstract]   [Full Text] [Related]  

  • 42. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation.
    Ueda Y; Takada Y; Marusawa H; Egawa H; Uemoto S; Chiba T
    Transplantation; 2010 Sep; 90(6):661-5. PubMed ID: 20110853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C: changing genotype distribution with important implications for patient management.
    van Soest H; Boland GJ; van Erpecum KJ
    Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between type II cryoglobulinemia and hepatitis C virus in a case treated with interferon-alpha.
    Fukumoto S; Ishimura E; Shoji S; Izumotani T; Kitahashi S; Kuroki T; Nishizawa Y; Morii H
    Nephron; 1996; 73(1):94-6. PubMed ID: 8742965
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute hepatitis C infection: an indication for alfa interferon therapy?
    van der Vlies CH; Tang TJ; Niesters HG; Zondervan PE; Janssen HL; de Man RA
    Neth J Med; 2000 Jul; 57(1):30-3. PubMed ID: 10863000
    [No Abstract]   [Full Text] [Related]  

  • 49. [HCV-RNA in liver of chronic hepatitis C--plus strand RNA and minus strand RNA].
    Endo H; Yamada G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):623-8. PubMed ID: 7563844
    [No Abstract]   [Full Text] [Related]  

  • 50. HCV findings presented at EASL: long-term follow-up and the criteria of a cure.
    Lang L
    Gastroenterology; 2007 Jun; 132(7):2282-3. PubMed ID: 17570197
    [No Abstract]   [Full Text] [Related]  

  • 51. Interferon for hepatitis C.
    Puoti C; Magrini A; Stati T; Rossi P; Montagnese F; Resta S
    Lancet; 1997 Feb; 349(9049):398-9. PubMed ID: 9033470
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained response to interferon in a patient with common variable immunodeficiency and hepatitis C.
    Castro F; Santaella M; Torres EA; Rodriguez-Medina JR; González-Keelan C
    Am J Gastroenterol; 1997 Sep; 92(9):1557-8. PubMed ID: 9317087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C virus RNA kinetics: drug efficacy and the rate of HCV-infected cells loss.
    Dahari H; Perelson AS
    World J Gastroenterol; 2007 Jun; 13(21):3020-1. PubMed ID: 17589958
    [No Abstract]   [Full Text] [Related]  

  • 55. Viral kinetics and hepatitis C.
    Lake-Bakaar G; Frost SD
    Hepatology; 2003 Dec; 38(6):1588; author reply 1588-1590. PubMed ID: 14647069
    [No Abstract]   [Full Text] [Related]  

  • 56. Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot study.
    Lee SS; Kilvert L; Liu H; Trepanier J
    Dig Liver Dis; 2016 Mar; 48(3):344. PubMed ID: 26459137
    [No Abstract]   [Full Text] [Related]  

  • 57. Successful treatment of membranoproliferative glomerulonephritis associated with hepatitis B and C virus simultaneous infection patient.
    Mima A; Iehara N; Matsubara T; Yamamoto S; Abe H; Nagai K; Matsuura M; Murakami T; Kishi S; Araoka T; Kishi F; Kondo N; Shigeta R; Yoshikawa K; Takahashi T; Kita T; Doi T; Fukatsu A
    Clin Nephrol; 2010 Feb; 73(2):167-9. PubMed ID: 20129026
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Genotype 1 superresponder treat for only 24 weeks].
    MMW Fortschr Med; 2005 Dec; 147(51-52):69. PubMed ID: 16402717
    [No Abstract]   [Full Text] [Related]  

  • 60. Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy.
    Lederer S; Zachoval R; Hasholzner U; Schiffl H
    Clin Nephrol; 2008 Apr; 69(4):313-6. PubMed ID: 18397710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.